The emergence and worldwide dissemination of SARS-CoV-2 required both urgent
development of new diagnostic tests and expansion of diagnostic testing capacity on an …

Neutralizing antibodies (nAbs) are considered a valuable marker for measuring humoral
immunity against SARS-CoV-2. However, live-virus neutralization tests (NTs) require high …

ABSTRACT The SARS-CoV-2 Omicron variant is characterized by substantial changes in
the antigenic structure of the Spike (S) protein. Therefore, antibodies induced by primary …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December
2019 and caused a dramatic pandemic. Serological assays are used to check for …

Simple Summary Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the
agent of the disease that has caused a global pandemic, known as coronavirus disease …

Vaccines are the most effective means to prevent the potentially deadly effects of SARS-CoV-
2 infection, but not all vaccinated individuals gain the same degree of protection. Patients …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
December 2019 and spread rapidly. The purpose of this study was to compare neutralizing …

There is evidence that vaccination against seasonal influenza can improve innate immune
responses to COVID-19 and decrease disease severity. However, less is known about …

The present study aimed to determine whether current commercial immunoassays are
adequate for detecting anti‐Omicron antibodies. We analyzed the anti‐SARS‐CoV‐2 …

Background: Humoral and cellular immune responses to SARS-CoV-2 vaccination among
immunosuppressed patients remain poorly defined, as well as variables associated with …